March 14, 2026 - 03:11

China has laid out a comprehensive five-year roadmap aimed at securing its position as a global leader in cutting-edge technology. The ambitious plan targets breakthroughs across a spectrum of futuristic fields, signaling a strategic push for industrial and scientific dominance.
Central to the initiative are advancements in next-generation artificial intelligence, with a focus on developing more powerful and adaptable AI systems. The blueprint also sets concrete goals for the emergence of disruptive transportation, explicitly calling for the development of flying cars. Furthermore, it delves into the integration of biology and machinery, outlining research into brain-computer interfaces and chip implants.
Adding to the vision, the plan promotes the innovation and deployment of humanoid robots, aiming to create intelligent machines capable of complex tasks. This wide-ranging strategy underscores a concerted national effort to master the foundational technologies of the future. By channeling resources and policy support into these frontier areas, China seeks to build new competitive industries and shape the trajectory of global technological progress in the coming decade.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...